- The approval is based on efficacy results from P-III studies involve assessing Zegalogue vs PBO in children aged 6-17yrs. and in adults with T1D
- The study met its 1EPs showed an increase in blood glucose of ≥20 mg/dL within 45 minutes, the median time to blood glucose recovery (10min vs 30-45min), following injection of 0.6 mg/0.6 ml of therapy, 99% of patients recovered within 15 minutes in adults
- Zegalogue will be available in both an auto-injector and a prefilled syringe to treat hypoglycemia in patients with diabetes aged ≥6yrs.
Click here to read full press release/ article | Ref: GlobeNewswire | Image: Zealand Pharma